168 related articles for article (PubMed ID: 34387300)
21. Defining functioning categories in axial Spondyloarthritis: the role of the ASAS Health Index.
Di Carlo M; Lato V; Di Matteo A; Carotti M; Salaffi F
Rheumatol Int; 2017 May; 37(5):713-718. PubMed ID: 28063070
[TBL] [Abstract][Full Text] [Related]
22. An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS.
Molto A; Gossec L; Meghnathi B; Landewé RBM; van der Heijde D; Atagunduz P; Elzorkany BK; Akkoc N; Kiltz U; Gu J; Wei JCC; Dougados M;
Ann Rheum Dis; 2018 Jan; 77(1):124-127. PubMed ID: 29038299
[TBL] [Abstract][Full Text] [Related]
23. ASAS Health Index in patients with spondyloarthritis and its association with disease activity and disease burden including fibromyalgia.
Puche Larrubia MÁ; Castro Villegas MC; Ortega Castro R; Garrido-Castro JL; Font-Ugalde P; Escudero-Contreras A; Ladehesa-Pineda L; Gómez García I; Collantes-Estévez E; López Medina C
Clin Exp Rheumatol; 2021; 39 Suppl 130(3):82-88. PubMed ID: 33635208
[TBL] [Abstract][Full Text] [Related]
24. Altered sleep in axial spondyloarthritis and psoriatic arthritis: Post hoc comparative study based on a sleep-specific question from the ASAS health index.
Alonso S; Morante I; Braña I; Queiro R
Reumatol Clin (Engl Ed); 2023 Oct; 19(8):430-435. PubMed ID: 37805256
[TBL] [Abstract][Full Text] [Related]
25. Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study.
Nikiphorou E; van der Heijde D; Norton S; Landewé RB; Molto A; Dougados M; Van den Bosch FE; Ramiro S
Ann Rheum Dis; 2018 Mar; 77(3):405-411. PubMed ID: 29222349
[TBL] [Abstract][Full Text] [Related]
26. [Effect of multimodal rheumatologic complex treatment in patients with axial spondylarthritis : A systematic evaluation with standardized outcome parameters, such as the ASAS Health Index].
Kiltz U; Wiatr T; Kiefer D; Baraliakos X; Braun J
Z Rheumatol; 2024 Mar; 83(2):153-159. PubMed ID: 35900591
[TBL] [Abstract][Full Text] [Related]
27. Smoking and alcohol consumption are associated with peripheral musculoskeletal involvement in patients with spondyloarthritis (including psoriatic arthritis). Results from the ASAS-PerSpA study.
Ladehesa-Pineda ML; Ortega-Castro R; Puche-Larrubia MÁ; Granados REM; Dougados M; Collantes-Estévez E; López-Medina C
Semin Arthritis Rheum; 2023 Feb; 58():152146. PubMed ID: 36516482
[TBL] [Abstract][Full Text] [Related]
28. Elucidating the role of a positive family history in differentiating between axial and peripheral spondyloarthritis: an ancillary analysis of the ASAS-PerSpA study.
Kwan YH; Tan L; Tan CS; López-Medina C; Dougados M; Proft F; Rios-Rodriguez V; Phang JK; Chew EH; Østbye T; Thumboo J; Fong W
Clin Exp Rheumatol; 2022 Sep; 40(9):1762-1768. PubMed ID: 34905484
[TBL] [Abstract][Full Text] [Related]
29. Effect of biologic disease-modifying anti-rheumatic drugs targeting remission in axial spondyloarthritis: systematic review and meta-analysis.
Cruz-Machado AR; Rodrigues-Manica S; Silva JL; Alho I; Coelho C; Duarte J; Florêncio C; Pimentel-Santos FM; Tavares-Costa J; Vieira-Sousa E
Rheumatology (Oxford); 2020 Nov; 59(11):3158-3171. PubMed ID: 32696064
[TBL] [Abstract][Full Text] [Related]
30. The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study.
Bakker P; Moltó A; Etcheto A; Van den Bosch F; Landewé R; van Gaalen F; Dougados M; van der Heijde D
Arthritis Res Ther; 2017 May; 19(1):96. PubMed ID: 28511725
[TBL] [Abstract][Full Text] [Related]
31. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
Kilic G; Kilic E; Ozgocmen S
Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
[TBL] [Abstract][Full Text] [Related]
32. Performance of the ASAS Health Index for the Evaluation of Spondyloarthritis in Daily Practice.
Alonso-Castro S; Pardo E; Charca L; Pino M; Fernández S; Alperi M; Arboleya L; Queiro R
J Rheumatol; 2020 Oct; 47(10):1483-1489. PubMed ID: 32358161
[TBL] [Abstract][Full Text] [Related]
33. Fatigue in early axial spondyloarthritis. Results from the French DESIR cohort.
Gossec L; Dougados M; D'Agostino MA; Fautrel B
Joint Bone Spine; 2016 Jul; 83(4):427-31. PubMed ID: 26709252
[TBL] [Abstract][Full Text] [Related]
34. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A
Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975
[TBL] [Abstract][Full Text] [Related]
35. Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.
Kiltz U; van der Heijde D; Boonen A; Akkoc N; Bautista-Molano W; Burgos-Vargas R; Wei JC; Chiowchanwisawakit P; Dougados M; Duruoz MT; Elzorkany BK; Gaydukova I; Gensler LS; Gilio M; Grazio S; Gu J; Inman RD; Kim TJ; Navarro-Compan V; Marzo-Ortega H; Ozgocmen S; Pimentel Dos Santos F; Schirmer M; Stebbings S; Van den Bosch FE; van Tubergen A; Braun J
Ann Rheum Dis; 2018 Sep; 77(9):1311-1317. PubMed ID: 29858176
[TBL] [Abstract][Full Text] [Related]
36. Role of Metrology in Axial Spondyloarthritis: Does It Provide Unique Information in Assessing Patients and Predicting Outcome? Results From the British Society for Rheumatology Biologic Register for Ankylosing Spondylitis.
Biallas RL; Dean LE; Davidson L; Hollick R; Pathan E; Robertson L; Jones GT; Macfarlane GJ; Rotariu O
Arthritis Care Res (Hoboken); 2022 Apr; 74(4):665-674. PubMed ID: 33140891
[TBL] [Abstract][Full Text] [Related]
37. Optimisation of rheumatology assessments - the actual situation in axial spondyloarthritis including ankylosing spondylitis.
Braun J; Kiltz U; Baraliakos X; van der Heijde D
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-96-104. PubMed ID: 25365096
[TBL] [Abstract][Full Text] [Related]
38. Residual Disease Burden in Patients With Axial Spondyloarthritis and Psoriatic Arthritis Despite Low Disease Activity States in a Multiethnic Asian Population.
Liu V; Fong W; Kwan YH; Leung YY
J Rheumatol; 2021 May; 48(5):677-684. PubMed ID: 33132217
[TBL] [Abstract][Full Text] [Related]
39. Assessing rheumatologists' attitudes and utilization of classification criteria for ankylosing spondylitis and axial spondyloarthritis: a global effort.
Rich-Garg N; Danve A; Choi D; Vakil-Gilani K; Akkoc N; Azevedo V; Russell A; Sharma A; Cush J; Curtis JR; Deodhar A
Clin Rheumatol; 2021 Mar; 40(3):949-954. PubMed ID: 32797363
[TBL] [Abstract][Full Text] [Related]
40. Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry.
Michelena X; Zhao SS; Dubash S; Dean LE; Jones GT; Marzo-Ortega H
Rheumatology (Oxford); 2021 Dec; 60(12):5795-5800. PubMed ID: 33502476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
